FFIV
52
3
HPE
63
4
HPQ
37
6
IRM
47
3
PBI
42
-4
ECL
59
-3
ADBE
44
3
MAT
30
-2
SRE
68
2
DVA
47
-4
AMGN
39
-5
BSX
42
2
ORLY
58
8
ADT
55
5
SJM
19
2
DG
57
7
CNP
70
2
SHW
43
-3
NRG
45
3
WM
80
6
FFIV
52
3
HPE
63
4
HPQ
37
6
IRM
47
3
PBI
42
-4
ECL
59
-3
ADBE
44
3
MAT
30
-2
SRE
68
2
DVA
47
-4
AMGN
39
-5
BSX
42
2
ORLY
58
8
ADT
55
5
SJM
19
2
DG
57
7
CNP
70
2
SHW
43
-3
NRG
45
3
WM
80
6
Financhill
Back

MiMedx Group, Inc. 10K Form

Sell
21

MDXG
MiMedx Group, Inc.

Last Price:
$3.92
Seasonality Move:
0.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MDXG News And Ratings

See the #1 stock for the next 7 days that we like better than MDXG

MDXG Financial Statistics

Sales & Book Value

Annual Sales: $418.6M
Cash Flow: $22.6M
Price / Cash Flow: 8.21
Annual Sales: $1.73
Price / Book: 2.25

Profitability

EPS (TTM): 0.32440
Net Income (TTM): $48.6M
Gross Margin: $344.2M
Return on Equity: 21.92%
Return on Assets: 16.33%

MiMedx Group, Inc. Earnings Forecast

Key MiMedx Group, Inc. Financial Ratios

  • The Gross Profit Margin over the past 19 years for MDXG is 82.22%.
  • The Selling, General & Administrative Expenses for MDXG have been equal to 63.59% of Gross Profit Margin.
  • The Research & Development expenses have been 3.51% of Revenue.
  • The Interest Expense is 3.67% of Operating Income.
  • The Net Earning history of MDXG is 11.60% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 12 years.

MiMedx Group, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MDXG
CUSIP: 602496
Website: mimedx.com

Debt

Debt-to-Equity Ratio: 0.09
Current Ratio: 4.32
Quick Ratio: 3.9

Price-to-Earnings

Trailing P/E Ratio: 11.98
Forward P/E Ratio: 15.09

MDXG Technical Analysis vs Fundamental Analysis

Sell
21
MiMedx Group, Inc. (MDXG) is a Sell

Is MiMedx Group, Inc. a Buy or a Sell?